Use of sacubitril/valsartan in acute decompensated heart failure: a case report

Refractory heart failure typically requires costly long‐term, continuous intravenous inodilator infusions while patients await mechanical circulatory support or cardiac transplantation. The combined angiotensin receptor blocker–neprilysin inhibitor, sacubitril/valsartan, is a novel therapy that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Taison D., Mazer, Adrien J., Miller, P. Elliott, Strich, Jeffrey R., Sachdev, Vandana, Wright, Mary E., Solomon, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793985/
https://www.ncbi.nlm.nih.gov/pubmed/29035000
http://dx.doi.org/10.1002/ehf2.12219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793985/
https://www.ncbi.nlm.nih.gov/pubmed/29035000
http://dx.doi.org/10.1002/ehf2.12219

Ejemplares similares